Picture of Adherium logo

ADR — Adherium News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's Adherium jumps after FDA clearance for inhalers

** Shares of Adherium Ltd  ADR.AX  climb as much as 16.7% to
A$0.004, their highest since March 13
    ** Respiratory e-health company says it has received U.S.
FDA 510(k) clearance for Teva Pharmaceutical Industries'
 TEVA.TA  HFA pressurised metered dose inhaler users to remotely
monitor physiological parameters
    ** Says clearance is for market application, connecting Teva
inhalers including ProAir® and Albuterol Sulphate with ADR's
Hailie® sensor with physiological parameters
    ** More than 15 mln shares change hands, twice the 30-day
average volume 
    ** Stock down 25% this year, as of last close


 (Reporting by Poonam Behura in Bengaluru)
 ((Poonam.Behura@thomsonreuters.com;))

Recent news on Adherium

See all news